Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

24. Februar 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 2960


	Artikel 1 - 20 / 59187

	The role of surgical resection, locoregional liver-directed treatments, and continuous systemic treatment in patients with liver metastatic pancreatic cancers. Int J Surg Li X, Qiao G, Chen Y, Gao F, Zhang X, Xiao W, Sun K, Sun X, Bai X, Liang T. PMID: 41731869 [PubMed - indexed for MEDLINE]
	Predictive model and novel classification of pancreatic fistula following minimally invasive enucleation: a prospective cohort study (CSPAC-MIEN-2). Int J Surg Wang T, Li Z, Shi Y, Dang Q, Wu J, Liu M, Chen H, Chen C, Xu W, Liu W, Zhou C, Zhuo Q, Ji S, Wang L, Qin Y, Yu X, Xu X. PMID: 41731864 [PubMed - indexed for MEDLINE]
	Exploring dietary habits strongly associated with pancreatic cancer from the perspective of Mendelian randomization. Medicine (Baltimore) Chen S, Liu Y, Fan T, Yuan H, Guo T, Wang J. PMID: 41731762 [PubMed - indexed for MEDLINE]
	EPI-X4 is a peptide antagonist of CXCR4 with therapeutic prospects for cancer and inflammatory disorders. Peptides Sagini MN, Berger MR, Muthmann J, Alt E, Forssmann WG. PMID: 41730454 [PubMed - as supplied by publisher]
	Stereotactic Adaptive Radiation Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer to Minimize Gastrointestinal Toxicity (ARTIA-Pancreas): Protocol for a Single-Arm Prospective Trial. JMIR Res Protoc Henke LE, Kim H, Laugeman E, Kohlmyer S, McCann C, Pietrovito K, Russell K, Woo J, Price AT. PMID: 41730182 [PubMed - indexed for MEDLINE]
	AI-Driven Patient Screening for Clinical Trials in Pancreatic Cancer: The PANCR-AI Pilot Retrospective Comparative Study. JMIR Cancer Claessens A, Simon A, Manchart A, Desmonts L, Leguay C, Faivre JC, Cambier S, Salleron J, Lambert A. PMID: 41730173 [PubMed - indexed for MEDLINE]
	From local control to immune modulation: hypofractionated radiotherapy as a backbone for cancer immunotherapy. Front Oncol Zhuang X, Sun Y, Zhuang D. PMID: 41727645 [PubMed]
	Comprehensive analysis of mitochondrial unfolded protein response related genes for prognosis and therapeutic response in pancreatic cancer. Front Immunol Li C, Lu C, Ma Z, Zhao T, Xiao M, Xu Z, Sun Z, Wu Q, Wang L, Zhao L. PMID: 41727504 [PubMed - indexed for MEDLINE]
	Multi-scale systems toxicology defines a KLF5-centered adverse outcome pathway linking DEHP exposure to pancreatic cancer progression and signaling programs relevant to therapy tolerance. Front Cell Dev Biol Chen J, Pang H, Wang J, Guo J, Huang T, Zhou H. PMID: 41727317 [PubMed]
	Molecular classification and prognosis study of pancreatic ductal adenocarcinoma through multi-omics integrated clustering analysis. PeerJ Zhong G, Wang L, Fu P, Xi B, Li H, Cheng Y, Lin J, Chen L. PMID: 41727227 [PubMed - indexed for MEDLINE]
	Cystic lesions and their role in pancreatic cancer risk stratification. Transl Oncol Lyons R, Maher SG, Lysaght J. PMID: 41724074 [PubMed - as supplied by publisher]
	Differentiating large-duct pancreatic ductal adenocarcinoma from malignant intraductal papillary mucinous neoplasm: MRI characteristics and diagnostic implications. Eur J Radiol Choi SJ, Kim DW, Jeong BK, Hong SM, Byun JH, Lee SS, Kim HJ, Kim JH, Song KB, Lee JH, Hwang DW. PMID: 41724060 [PubMed - as supplied by publisher]
	Epigenetic modulation to overcome immune suppression in pancreatic cancer. Clin Epigenetics Drndakova L, Juhasikova L, Hlavenova I, Buocikova V, Durdiakova S, Mego M, Buc M, Smolkova B. PMID: 41723543 [PubMed - as supplied by publisher]
	Real-world oncological and pathological outcomes after neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic cancer: A propensity score-matched cohort study. Surg Oncol Taguchi M, Sasanuma H, Shimodaira K, Kimura Y, Aoki Y, Meguro Y, Kasahawa N, Morishima K, Miyato H, Ohzawa H, Miki A, Kaneda Y, Endo K, Koizumi M, Sakuma Y, Yamashita H, Horie H, Sata N, Yamaguchi H. PMID: 41722208 [PubMed - as supplied by publisher]
	Turning pancreatic cancer from cold to hot: the promise of a p53-expressing oncolytic adenovirus (OBP-702). Int J Clin Oncol Kuroda S, Tazawa H, Hashimoto M, Kanaya N, Kakiuchi Y, Kagawa S, Urata Y, Fujiwara T. PMID: 41721933 [PubMed - as supplied by publisher]
	Iodine-125 Brachytherapy Combined with Biliary Stenting in Advanced Pancreatic Cancer: A Clinical Application Study. Acad Radiol Sun H, Zhou Y, Li G, Wang F, Huo Z, Shuai J, Yan Z, Liu L, Chen Y. PMID: 41720727 [PubMed - as supplied by publisher]
	Targeted cancer therapy using single- and multi-drug loaded nanoformulations: a comprehensive review. J Biomater Sci Polym Ed Nurdogan AN, Karatug Kacar A. PMID: 41719476 [PubMed - as supplied by publisher]
	Coagulation disorders and thromboprophylaxis in pancreatic cancer: a review of current evidence and clinical challenges. J Thromb Thrombolysis Grochowska A, Kaczorowska J, , Ciesielski W, Durczy, Strzelczyk J, Hogendorf P. PMID: 41718997 [PubMed - as supplied by publisher]
	Prospective Registry and Meta-Analysis of Particle Therapy for Hepatocellular Carcinoma: Clinical Outcomes and Real-World Impact. Cancer Med Mizumoto M, Shibuya K, Terashima K, Iwata H, Saito T, Toyama S, Ogino T, Murakami M, Ohno T, Sato Y, Akimoto T, Katoh H, Wakatsuki M, Waki T, Katoh N, Koizumi F, Araya M, Onoe T, Takagi M, Okimoto T, Ogino H, Numajiri H, Shioyama Y, Hashimoto T, Ohba H, Kubo S, Hasegawa K, Maruo K, Aoyama H, Sakurai H. PMID: 41717812 [PubMed - indexed for MEDLINE]
	TRIM16: a context-dependent E3 ligase in autophagy, oxidative stress, and immune regulation - from cancer and systemic disease. Front Oncol Dong H, Jiang J, Ni K, Ren Q, Yang X, Shang L, Cai B, Li L. PMID: 41717414 [PubMed]

Artikel 1 - 20 / 59187

Seite 1 von 2960



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung